Hospitalizations for varicella in the United States, 1988 to 1999

Pediatric Infectious Disease Journal

Volumn 21, Issue 10, 2002, Pages 931-934

  Galil, Karin ^a   Brown, Cedric ^a   Lin, Felix ^a   Seward, Jane ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Hospitalization; National Hospital Discharge Survey; Varicella; Varicella epidemiology; Varicella morbidity; Varicella vaccine

Indexed keywords

CHICKENPOX VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHICKENPOX; CHILD; CHILD HOSPITALIZATION; ELECTROLYTE DISTURBANCE; FEMALE; HEALTH STATISTICS; HOSPITAL DISCHARGE; HUMAN; IMMUNE DEFICIENCY; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SOFT TISSUE INFECTION; UNITED STATES; VACCINATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; FEMALE; HEALTH SURVEYS; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; PROBABILITY; REFERENCE VALUES; REGISTRIES; RISK FACTORS; SEX DISTRIBUTION; UNITED STATES; VACCINATION;

EID: 0036798070     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200210000-00009     Document Type: Article

References (13)

1. Seward JF, Watson BM, Peterson CL, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 2002;287:606-11.
2. National Center for Health Statistics. Public use data tape documentation. Part I. National Health Interview Survey, 1988-1995 [machine-readable data file and documentation]. Hyattsville, MD: National Center for Health Statistics (producer). Springfield, VA: National Technical Information Service, US Department of Commerce (distributor).
3. Strichartz, Robert S. The way of analysis. Boston: Jones and Bartlett, 1995:181-5, 292-4.
4. Amler RW. The health impact of varicella. In: Proceedings of the 17th Immunization Conference, Atlanta, 1982. Atlanta, GA: Centers for Disease Control, 1982.
5. Law B, Scheifele D, MacDonald N, et al. The Immunization Monitoring Program-active (IMPACT) prospective surveillance of varicella zoster infections among hospitalized Canadian Children: 1991-1996. Can Commun Dis Rep 2000;26:125-31.
6. Meyer P, Seward J, Jumaan A, Wharton M. Varicella mortality: trends before vaccine licensure in the United States, 1970-1994. J Infect Dis 2000;182:383-90.
7. Choo PW, Donahue JG, Manson JE, Platt R. The epidemiology of varicella and its complications. J Infect Dis 1995;172:706-12.
8. Law B, Fitzsimon C, Ford-Jones L, McCormick J, Riviere M. Cost of chickenpox in Canada: part II. Cost of complicated cases and total economic impact. The Immunization Monitoring Program-Active (IMPACT). Pediatrics 1999;104(1 Pt 1):7-14.
9. Manfredi R, Chiodo F, Titone L, et al. Chickenpox complications among immunocompetent hospitalized children in Italy. Acyclovir-Chickenpox Italian Study Group. Pediatr Med Chir (Med Surg Pediatr) 1997;19:99-104.
10. Gray GC, Palinkas LA, Kelley PW. Increasing incidence of varicella hospitalizations in United States Army and Navy personnel: are today's teenagers more susceptible? Should recruits be vaccinated? Pediatrics 1990;86:867-73.
11. Herrin VE, Gray GC. Decreasing rates of hospitalization for varicella among young adults. J Infect Dis 1996;174:835-8.
12. CDC. Status report on the Childhood Immunization Initiative: national, state and urban area vaccination coverage levels among children aged 19-35 months - United States, 1996. MMWR 1997;46:657-65.
13. CDC. National, state, and urban area vaccination coverage levels among children aged 19-35 months: United States, 1999. MMWR 2000;49:585-9.